Home Sporadic pediatric papillary thyroid carcinoma harboring the ETV6/NTRK3 fusion oncogene in a 7-year-old Japanese girl: a case report and review of literature
Article
Licensed
Unlicensed Requires Authentication

Sporadic pediatric papillary thyroid carcinoma harboring the ETV6/NTRK3 fusion oncogene in a 7-year-old Japanese girl: a case report and review of literature

  • Ryota Otsubo EMAIL logo , Zhanna Mussazhanova , Yuko Akazawa , Ayako Sato , Katsuya Matsuda , Megumi Matsumoto , Hiroshi Yano , Michiko Matsuse , Norisato Mitsutake , Takao Ando , Daisuke Niino , Takeshi Nagayasu and Masahiro Nakashima
Published/Copyright: February 10, 2018

Abstract

Background:

There have been great concerns about pediatric thyroid cancers after the accident at the Fukushima Daiichi Nuclear Power Plant in 2011.

Case presentation:

We report a case of a 7-year-old Japanese girl with sporadic papillary thyroid carcinoma (PTC) harboring an ETV6/NTRK3 rearrangement. The patient presented with tumors in both lobes and underwent thyroidectomy followed by radioactive iodine (RAI) ablation. Histopathology showed a classic type of PTC with cervical lymph node metastasis.

Conclusions:

Genetic evaluation showed ETV6/NTRK3 fusion but no BRAF mutations or RET/PTC rearrangements. RET/PTC rearrangement and BRAF mutations often contribute to the pathogenesis of PTC; however, rearrangements of NTRK genes are relatively rare in pediatric PTC. Although NTRK rearrangement has been shown to often present unique pathological types and infiltrative architectures in the western population, such findings were not observed in this patient. Thus, the present case of classic PTC with ETV6/NTRK3 rearrangement highlights the disparate collection of clinic-pathological features compared to the trend in the western population. We therefore emphasize the need to further accumulate clinical as well as genetic data in pediatric PTCs.


Corresponding author: Ryota Otsubo, MD, PhD, Division of Surgical Oncology, Nagasaki University Hospital, Nagasaki, Japan, Phone: +81-95-819-7304, Fax: +81-95-819-7306
aZhanna Mussazhanova and Yuko Akazawa contributed equally to this work.

Acknowledgments

We gratefully acknowledge the assistance of Dr. Sumito Dateki in preoperative diagnosis and hospitalization management. This work was supported in part through the Atomic Bomb Disease Institute, Nagasaki University, and by a Grant-in-Aid for Scientific Research from the Japanese Ministry of Education, Science, Sports, and Culture (No. 16K08714).

  1. Author contributions: All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.

  2. Research funding: None declared.

  3. Employment or leadership: None declared.

  4. Honorarium: None declared.

  5. Competing interests: The funding organization(s) played no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the report for publication.

References

1. Cordioli MI, Moraes L, Bastos AU, Besson P, Alves MT, et al. Fusion oncogenes are the main genetic events found in sporadic papillary thyroid carcinomas from children. Thyroid 2017;27:182–8.10.1089/thy.2016.0387Search in Google Scholar PubMed

2. Prasad ML, Vyas M, Horne MJ, Virk RK, Morotti R, et al. NTRK fusion oncogenes in pediatric papillary thyroid carcinoma in northeast United States. Cancer 2016;122:1097–107.10.1002/cncr.29887Search in Google Scholar PubMed

3. Niedziela M. Pathogenesis, diagnosis and management of thyroid nodules in children. Endocr Relat Cancer 2006;13:427–53.10.1677/erc.1.00882Search in Google Scholar PubMed

4. Ricarte-Filho JC, Li S, Garcia-Rendueles ME, Montero-Conde C, Voza F, et al. Identification of kinase fusion oncogenes in post-Chernobyl radiation-induced thyroid cancers. J Clin Invest 2013;123:4935–44.10.1172/JCI69766Search in Google Scholar PubMed PubMed Central

5. Mitsutake N, Fukushima T, Matsuse M, Rogounovitch T, Saenko V, et al. BRAF(V600E) mutation is highly prevalent in thyroid carcinomas in the young population in Fukushima: a different oncogenic profile from Chernobyl. Sci Rep 2015;5:16976.10.1038/srep16976Search in Google Scholar PubMed PubMed Central

6. Fridman MV, Savva NN, Krasko OV, Zborovskaya AA, Mankovskaya SV, et al. Clinical and pathologic features of “sporadic” papillary thyroid carcinoma registered in the years 2005 to 2008 in children and adolescents of Belarus. Thyroid 2012;22:1016–24.10.1089/thy.2011.0005Search in Google Scholar PubMed

7. Sugino K, Nagahama M, Kitagawa W, Shibuya H, Ohkuwa K, et al. Papillary thyroid carcinoma in children and adolescents: long-term follow-up and clinical characteristics. World J Surg 2015;39:2259–65.10.1007/s00268-015-3042-4Search in Google Scholar PubMed

8. Cancer Genome Atlas Research Network. Integrated genomic characterization of papillary thyroid carcinoma. Cell 2014; 159:676–90.10.1016/j.cell.2014.09.050Search in Google Scholar PubMed PubMed Central

9. Soares P, Trovisco V, Rocha AS, Lima J, Castro P, et al. BRAF mutations and RET/PTC rearrangements are alternative events in the etiopathogenesis of PTC. Oncogene 2003; 22:4578–80.10.1038/sj.onc.1206706Search in Google Scholar PubMed

10. Rossi M, Buratto M, Tagliati F, Rossi R, Lupo S, et al. Relevance of BRAF(V600E) mutation testing versus RAS point mutations and RET/PTC rearrangements evaluation in the diagnosis of thyroid cancer. Thyroid 2015;25:221–8.10.1089/thy.2014.0338Search in Google Scholar PubMed PubMed Central

11. Niemeier LA, Kuffner Akatsu H, Song C, Carty SE, Hodak SP, et al. A combined molecular-pathologic score improves risk stratification of thyroid papillary microcarcinoma. Cancer 2012;118:2069–77.10.1002/cncr.26425Search in Google Scholar PubMed PubMed Central

12. Xing M, Alzahrani AS, Carson KA, Shong YK, Kim TY, et al. Association between BRAF V600E mutation and recurrence of papillary thyroid cancer. J Clin Oncol 2015;33:42–50.10.1200/JCO.2014.56.8253Search in Google Scholar PubMed PubMed Central

13. Penko K, Livezey J, Fenton C, Patel A, Nicholson D, et al. BRAF mutations are uncommon in papillary thyroid cancer of young patients. Thyroid 2005;15:320–5.10.1089/thy.2005.15.320Search in Google Scholar PubMed

14. Rosenbaum E, Hosler G, Zahurak M, Cohen Y, Sidransky D, et al. Mutational activation of BRAF is not a major event in sporadic childhood papillary thyroid carcinoma. Mod Pathol 2005;18:898–902.10.1038/modpathol.3800252Search in Google Scholar PubMed

15. Leeman-Neill RJ, Kelly LM, Liu P, Brenner AV, Little MP, et al. ETV6-NTRK3 is a common chromosomal rearrangement in radiation-associated thyroid cancer. Cancer 2014;120:799–807.10.1002/cncr.28484Search in Google Scholar PubMed PubMed Central

16. Knezevich SR, McFadden DE, Tao W, Lim JF, Sorensen PH. A novel ETV6-NTRK3 gene fusion in congenital fibrosarcoma. Nature Genet 1998;18:184–7.10.1038/ng0298-184Search in Google Scholar PubMed

17. Rubin BP, Chen CJ, Morgan TW, Xiao S, Grier HE, et al. Congenital mesoblastic nephroma t(12;15) is associated with ETV6-NTRK3 gene fusion: cytogenetic and molecular relationship to congenital (infantile) fibrosarcoma. Am J Pathol 1998;153:1451–8.10.1016/S0002-9440(10)65732-XSearch in Google Scholar PubMed PubMed Central

18. Tognon C, Knezevich SR, Huntsman D, Roskelley CD, Melnyk N, et al. Expression of the ETV6-NTRK3 gene fusion as a primary event in human secretory breast carcinoma. Cancer Cell 2002;2:367–76.10.1016/S1535-6108(02)00180-0Search in Google Scholar

19. Eguchi M, Eguchi-Ishimae M, Tojo A, Morishita K, Suzuki K, et al. Fusion of ETV6 to neurotrophin-3 receptor TRKC in acute myeloid leukemia with t(12;15)(p13;q25). Blood 1999;93:1355–63.10.1182/blood.V93.4.1355Search in Google Scholar

20. Carroll M, Tomasson MH, Barker GF, Golub TR, Gilliland DG. The TEL/platelet-derived growth factor beta receptor (PDGF beta R) fusion in chronic myelomonocytic leukemia is a transforming protein that self-associates and activates PDGF beta R kinase-dependent signaling pathways. Proc Natl Acad Sci USA 1996;93:14845–50.10.1073/pnas.93.25.14845Search in Google Scholar PubMed PubMed Central

21. Golub TR, Goga A, Barker GF, Afar DE, McLaughlin J, et al. Oligomerization of the ABL tyrosine kinase by the Ets protein TEL in human leukemia. Mol Cell Biol 1996;16:4107–16.10.1128/MCB.16.8.4107Search in Google Scholar PubMed PubMed Central

Received: 2017-7-26
Accepted: 2017-12-22
Published Online: 2018-2-10
Published in Print: 2018-3-28

©2018 Walter de Gruyter GmbH, Berlin/Boston

Articles in the same Issue

  1. Frontmatter
  2. Original Articles
  3. HbA1c levels in children with type 1 diabetes and correlation to diabetic retinopathy
  4. Relationship between urinary sodium-creatinine ratios and insulin resistance in Korean children and adolescents with obesity
  5. Prevalence of comorbid conditions pre-existing and diagnosed at a tertiary care pediatric weight management clinic
  6. The relationship between diet quality and insulin resistance in obese children: adaptation of the Healthy Lifestyle-Diet Index in Turkey
  7. Outcomes of mitochondrial derived diseases: a single-center experience
  8. Metabolic and genetic markers’ associations with elevated levels of alanine aminotransferase in adolescents
  9. Phenotypic presentation of adolescents with overt primary hypothyroidism
  10. Growth velocity and biological variables during puberty in achondroplasia
  11. Employing a results-based algorithm to reduce laboratory utilization in ACTH stimulation testing
  12. Investigating the changes in amino acid values in premature infants: a pilot study
  13. A hierarchical Bayesian tri-variate analysis on factors associated with anthropometric measures in a large sample of children and adolescents: the CASPIAN-IV study
  14. Smith-Lemli-Opitz syndrome: clinical and biochemical correlates
  15. Case Reports
  16. Sporadic pediatric papillary thyroid carcinoma harboring the ETV6/NTRK3 fusion oncogene in a 7-year-old Japanese girl: a case report and review of literature
  17. Hypercalcemia, hyperkalemia and supraventricular tachycardia in a patient with subcutaneous fat necrosis
  18. Late presentation of glycogen storage disease types Ia and III in children with short stature and hepatomegaly
  19. A novel paraneoplastic syndrome with acquired lipodystrophy and chronic inflammatory demyelinating polyneuropathy in an adolescent male with craniopharyngioma
Downloaded on 16.9.2025 from https://www.degruyterbrill.com/document/doi/10.1515/jpem-2017-0292/html
Scroll to top button